ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
ZEO Scientifix Inc (QB)

ZEO Scientifix Inc (QB) (ZEOX)

2.64
-0.23
(-8.01%)
Cerrado 27 Febrero 3:00PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
2.64
Postura de Compra
2.41
Postura de Venta
2.87
Volume Operado de la Acción
280
2.64 Rango del Día 2.87
0.80 Rango de 52 semanas 4.73
Precio Anterior
2.87
Precio de Apertura
2.87
Última hora de negociación
Volumen promedio (3 m)
3,788
Volumen financiero
US$ 781
Precio Promedio Ponderado
2.7879

ZEOX Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.365-12.1464226293.0053.012.6424312.79604854CS
40.010.3802281368822.633.352.638402.99039106CS
12-0.43-14.0065146583.073.811.751237882.85889002CS
260.7841.9354838711.864.731.5148842.62007299CS
52-0.35-11.70568561872.994.730.847112.22148984CS
156-0.35-11.70568561872.994.730.847112.22148984CS
260-0.35-11.70568561872.994.730.847112.22148984CS

ZEOX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de ZEO Scientifix (QB)?
El precio actual de las acciones de ZEO Scientifix (QB) es US$ 2.64
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de ZEO Scientifix (QB)?
ZEO Scientifix (QB) ha negociado en un rango de US$ 0.80 a US$ 4.73 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
OOGIC2E Energy Inc (CE)
US$ 0.0002
(19,900.00%)
283
MADIMadison Systems Inc (CE)
US$ 0.0249
(12,350.00%)
300
SSTTSStarTrade Tech Inc (CE)
US$ 0.0001
(9,900.00%)
560
GLUXGreat Lakes Aviation Ltd (CE)
US$ 0.0001
(9,900.00%)
198.55k
PPRGPatient Portal Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
27.58k
STTOSITO Mobile Ltd (CE)
US$ 0.000001
(-99.98%)
834
DTEMFDitem Explorations (CE)
US$ 0.000001
(-99.90%)
2k
ASTOAstro Communications Inc (PK)
US$ 0.0101
(-99.69%)
750
PLFXPulse Evolution Corporation (CE)
US$ 0.000001
(-99.67%)
100
THBDThird Bench Inc (PK)
US$ 0.000001
(-99.50%)
69.06k
HMBLHUMBL Inc (PK)
US$ 0.0004
(-20.00%)
262.15M
ENDVEndonovo Therapeutics Inc (PK)
US$ 0.0002
(-33.33%)
226.03M
RDARRaadr Inc (PK)
US$ 0.0008
(0.00%)
195.26M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0003
(0.00%)
163.08M
TPTWTPT Global Tech Inc (PK)
US$ 0.0002
(0.00%)
112.94M

ZEOX Discussion

Ver más
bi0drag0n bi0drag0n 3 meses hace
I came across some news about ZEO ScientifiX, partnering with Exotropin to launch a new hair growth product called ZEO HAIR GROW™. This one caught my eye because it’s combining extracellular vesicles (EVs) from sources like amniotic fluid and stromal cells with natural ingredients, which is not something I’ve seen often in hair regrowth treatments.

From what I’ve read, they’re rolling it out at a medical aesthetics conference this week, and it sounds like they’re trying to tackle a big market here, with hair loss affecting millions in the U.S. alone. Curious if anyone else has looked into this company or has thoughts on partnerships like these in the biotech world.
https://finance.yahoo.com/news/zeo-scientifix-exotropin-join-forces-110000702.html
👍️0
Renee Renee 12 meses hace
OCEL: effective March 5,2024 Organicell Regenerative Medicine Inc, OCEL, will change to Zeo ScientifiX Inc, ZEOX:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
backtoreality backtoreality 1 año hace
There aren't many shares after the RS so it'll move.
👍️0
BLUEVOODU BLUEVOODU 1 año hace
Thank you - I think the thing that bothers me most over the last year is the lack of news.

After all the changes in leadership, the money they sunk into Ocel … etc… the lack of news is interesting.

Maybe something is brewing again. Lol Let’s go $20. We are only $16.80 away
👍️0
backtoreality backtoreality 1 año hace
Wishing you the best Blue!
👍️0
BLUEVOODU BLUEVOODU 1 año hace
Interesting action as of late. Nice increases.

I’m trying to find news as to what’s happening and cannot. However, we are hovering close to $3.50 a share now.

Let’s go! And let there be great news.
👍️0
backtoreality backtoreality 1 año hace
OTC is a crap shoot. I have a few stocks where management is very quite. The new Regulations may have company's worried about what they say and do.

Ocel got flagged for something like that as well. Best of luck to you. Hopefully the OTC makes a turn around and volume will pick up. But as far as I'm concerned everything is a shit show as well as the stock market.

Hopefully the country gets it right this time in 2024 or I'll be moving to Mexico and praying they don't cut social security .

Good luck. If they get FDA approval to move forward things can change fast. I met a guy on a plane. 62, a healthy firefighter that suddenly got sick. He needs a heart transplant and all they tell him it has something to do with covid....
👍️0
BLUEVOODU BLUEVOODU 1 año hace
I still have a decent amount of shares. It would take a significant run to get me back to even. Made money in covid run too.

I’m not holding my breath right now. I really don’t like R/S’s. It tends to be the kiss of death to value 95% of the time.

They’re not putting out any news. No news about internal structure… or product. I was hopeful with the management changes.
👍️0
backtoreality backtoreality 1 año hace
Fortunately I made some $ when they had their covid run.
👍️0
bude bude 1 año hace
Yes, has rs’d twice pass 3 years 1st split my shares down to 12. Last split down to one.
👍️0
backtoreality backtoreality 1 año hace
Do you have many shares left post split? I dumped most. Was it 500 to 1 split?

They stated it would crush retail. If the drug gets FDA approval it should take off.
👍️0
BLUEVOODU BLUEVOODU 1 año hace
Still around! It’s been very busy.

Saw the r/s was approved.
👍️0
backtoreality backtoreality 1 año hace
You still around
👍️0
Renee Renee 1 año hace
OCEL: effective Nov. 28,2023 a one for 200 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
backtoreality backtoreality 1 año hace
They have been Very transparent that this RSb1 for 500bshares will happen
👍️0
BLUEVOODU BLUEVOODU 1 año hace
Did they announce that was happening. Or did it get approved? I lost track for a bit.

They’re definitely dipping today
👍️0
bransteff bransteff 1 año hace
Yup terrible for retail
👍️0
backtoreality backtoreality 1 año hace
1 share for every 500. Bye bye retail
👍️0
bransteff bransteff 2 años hace
Let's gooo
👍️0
backtoreality backtoreality 2 años hace
I dumped half my holding here as soon as I heard RS. And my luck they'll get a big cash infusion from a gooverment grant.
👍️0
ErnieBilco ErnieBilco 2 años hace
Long odds on it uplisting, not many .01 stocks make it to the big boards.

BUT, insiders did buy 2.77 million shares in the past month or so so something is about to happen. Most of the buys were sub penny.

Watching from the sidelines unless my bait get grabbed.
👍️0
backtoreality backtoreality 2 años hace
Well if they were going to follow it with an immediate uplist it could work but in most cases the stock will get shorted to hell and back.
👍️0
ErnieBilco ErnieBilco 2 años hace
The ratio is up to 300 to 1 - that's not just a lil share structure adjustment - that is crap you would see the gooberment do.
👍️0
backtoreality backtoreality 2 años hace
Well anytime there's a mention of reverse split the stock price tanks. So far she's holding up.
👍️0
backtoreality backtoreality 2 años hace
Well there it is. Figured it would happen.
👍️0
backtoreality backtoreality 2 años hace
So the drug looks good safety wise. P 2 is on deck, but will require Funding. At 2 pennies a share selling shares won't cut it. They need grants or maybe even some type of partnership.
👍️0
backtoreality backtoreality 2 años hace
Perhaps the company is getting smart and will stop trying to raise funds when the momo isn't there?

They are recruiting for a trial at this time.Not sure why you said they're not in trials? Wish we could get an update but the crooked OTC slapped them with some BS and they maybe playing there hand close to the chest
👍️0
fourcloze fourcloze 2 años hace
Yup, well, there ya go. Down 16% today. If this thing did hit and actually had real trials that worked and FDA approved, I'd be set I think. Good luck.

-OUT-
👍️0
backtoreality backtoreality 2 años hace
I was referring to in the "short term" not my long term outlook.

I've been here since they first announced having a potential covid drug 3 ish years ago. I buy n sell their shares as I see fit. If this trend keeps going up I will be a very happy investor.

GLTU looking at the chart it appears the trend is going up and hope it sustains higher highs and lows. Good timing on your part.
👍️0
fourcloze fourcloze 2 años hace
lol, thought you were 'suckered' in last time?
👍️0
backtoreality backtoreality 2 años hace
Folks sitting on the fence may want to start accumulating .
👍️0
backtoreality backtoreality 2 años hace
I got suckered in to buying the last time it popped only to have it drop back down under a penny.
👍️0
BLUEVOODU BLUEVOODU 2 años hace
Also looks like the old director has resigned… the one they accused of mishandling business.

Turn around coming? Wish I had bought more lower.
👍️0
BLUEVOODU BLUEVOODU 2 años hace
Looks like more insider investment over the last couple days
👍️0
bransteff bransteff 2 años hace
Looking good
👍️0
backtoreality backtoreality 2 años hace
Yup, don't know what it will amount too.
👍️0
BLUEVOODU BLUEVOODU 2 años hace
Pretty Weighty... Did anyone see this?
http://archive.fast-edgar.com/20230609/APZ2L22CN222M2ZH222B22ZYGM3Q422SZ252/
👍️0
backtoreality backtoreality 2 años hace
Ba s tards taking it back. Faked me into buying rinse n repeat
👍️0
backtoreality backtoreality 2 años hace
It sure seems like we are basing at a new level.
👍️0
backtoreality backtoreality 2 años hace
That's because of them getting that slap on the wrist by the Regulators maybe. Also as long as they are recruiting there really is nothing to report. Recruiting is expected to last till the end of this year
👍️0
BLUEVOODU BLUEVOODU 2 años hace
It’s interesting as there is absolutely no news. Nothing more from new management. Etc.
👍️0
backtoreality backtoreality 2 años hace
I'd keep cash on hand and keep an eye out for news so you can buy asap if news hits. I don't think there are many eyes on this.
👍️0
BLUEVOODU BLUEVOODU 2 años hace
It’s tempting to buy more. But there’s absolutely no news. Everything went silent
👍️0
backtoreality backtoreality 2 años hace
Bottom in?
👍️0
backtoreality backtoreality 2 años hace
I'm seeing more energy in otc plays.

Ocel has backing to finance this P1 trial for a unmet issue copd. Especially when covid really does damage to those with these pre conditions.

Price is right for a Risk Reward play
👍️0
backtoreality backtoreality 2 años hace
Let's see where we are end of week..
👍️0
backtoreality backtoreality 2 años hace
Is the bottom in?
👍️0
backtoreality backtoreality 2 años hace
Is the Bottom in. TIME WILL TELL
👍️0
backtoreality backtoreality 2 años hace
Why invest here on speculation of what may transpire with the copd trial. They will dilute the share price so low that if Zofin ends up showing promise an investor will have time to load up sub pennyish.
👍️0
backtoreality backtoreality 2 años hace
Why invest here on speculation of what may transpire with the copd trial. They will dilute the share price so low that if Zofin ends up showing promise an investor will have time to load up sub pennyish.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock